Global Engage are proud to announce our 3rd Asia
Pharma R&D Outsourcing Congress which will be held on
November 21-22 in San Diego, CA, USA.
Outsourcing of preclinical development is projected to
increase by up to 50% in the next few years. As R&D
outsourcing continues to gain momentum, increasing numbers
of countries have sought to create an infrastructure that
will support discovery through academic innovation and
government investment. This has created a scenario where
the Asia Pacific region is developing fully outsourced
drug discovery programs from lead identification through
to lead optimization and beyond. With increasing
preclinical investment in Asia it is important to seek
outsourcing strategies that will minimize risk and
maximize returns - to learn critical factors, tips and
what to expect.
The 3rd congress will build upon the success of last
year’s APRDOC and examine how the Asia Pacific region has
developed as a potential partner for outsourcing drug
discovery programs. With a particular focus on preclinical
outsourcing, the conference will center on the key issues
facing those new to and already outsourcing R&D
efforts to Asia. Addressing the need to protect
intellectual property, keep up to date with continually
developing regional regulation and identify partnerships
within chemistry, biology and biologics outsourcing; the
congress will seek to improve successes and examine best
practice techniques, innovative strategies, and business
models in order to minimize expenses and develop pipelines
during a time of soaring R&D costs.
Held on the West Coast to enable easy access for US based
attendees, as well as attracting representatives from the
growing Asian market - the conference will include topics
such as:
Asia R&D
Outsourcing Strategies CRO Selection and
Management IP, Regulations and
GxP Scientific Research
Outsourcing
The 2013 Congress is under
development. This year's Advisory Board consists of:
Christopher Bi External
Research Solutions Chemistry Lead
Pfizer
Jane Clark Partner, Intellectual Property Group Gowling Lafleur
Henderson LLP
John Ellingboe Senior
Vice President, Discovery Chemistry
GVK Bio
Hans-Jürgen Federsel Senior Principal Scientist, Chemical
Science AstraZeneca
James Garner Vice
President & General Manager Takeda Global Research & Development
Center, Singapore
Hubert Haag Director, Global Sourcing &
External Business Opportunities Lead Generation & Candidate
Realization Sanofi-Aventis
Deutschland GmbH
Plus:
Scott Alban
Vice President, Global Intellectual Property,
Innovative Medicines & MedImmune R&D,
Legal
Giles Brown
Associate Director, Heptares Therapeutics
Limited
Stevan Djuric
Senior Director, AbbVie Inc.
John Feder
Associate Director of Genome Biology,
Bristol Myers-Squibb
Shengfang Jin Head of Strategic Outsourcing &
Senior Director Biology Agios
Pharmaceuticals Inc
Sham
Nikam VP, Head
of Extra Value Generation and General Medicine
Drug Discovery Unit
Takeda
Garry Pairaudeau Director, Research Outsourcing AstraZeneca
Andrew Parsons VP Preclinical Drug Development GSK
Rivka Ravid Director Brain
Bank Consultants, Senior
Scientist, Netherlands Institute
for Neurosciences Senior
Scientist, Royal Dutch Academy of
Sciences Amsterdam
Sylvie K. Sakata, PhD Senior Director, Head of External Research Solutions Pfizer Inc.
La Jolla and St Louis Lead External Research
Solutions RCoE
Saryu
Goel
Associate Director & Project Leader,
Supernus Pharmaceuticals Inc
Hasse Kromann
Head of Partnership Management, Research and
Innovation, LEO Pharma
Andy Takle
Director, Open Innovation, Eisai Pharmaceuticals
The Agenda and speaker
list will be released in August. To receive the
first updates and get special offers before anyone else,
please complete the form below.
Gold Sponsor
Other Sponsors
Copyright: Global Engage Ltd.
Registered in England. No: 6950636
Jane Clark
Hans-Jürgen Federsel
James Garner
Shengfang Jin
Sham
Nikam
Andrew Parsons
